Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS) : A nationwide randomised controlled trial. / Salem, Hanin; Kazak, Anne E.; Andersen, Elisabeth Wreford; Belmonte, Federica; Johansen, Christoffer; Schmiegelow, Kjeld; Winther, Jeanette Falck; Wehner, Peder Skov; Hasle, Henrik; Rosthøj, Steen; Bidstrup, Pernille E.
In: Pediatric Blood and Cancer, Vol. 68, No. 3, e28853, 2021.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS)
T2 - A nationwide randomised controlled trial
AU - Salem, Hanin
AU - Kazak, Anne E.
AU - Andersen, Elisabeth Wreford
AU - Belmonte, Federica
AU - Johansen, Christoffer
AU - Schmiegelow, Kjeld
AU - Winther, Jeanette Falck
AU - Wehner, Peder Skov
AU - Hasle, Henrik
AU - Rosthøj, Steen
AU - Bidstrup, Pernille E.
PY - 2021
Y1 - 2021
N2 - Introduction: Evidence-based knowledge is needed to reduce psychological symptoms in families of young children with cancer after treatment ends. Objective: To evaluate the effect of a psychotherapeutic intervention, FAMily-Oriented Support (FAMOS) on parents of young children after cancer treatment. Methods: All families of children aged 0-6 years who had been treated for cancer at one of the four paediatric oncology departments in Denmark were invited to participate after ending intensive medical treatment. The families were randomly assigned 1:1 to up to seven sessions of FAMOS, a cognitive-behavioural manualised home intervention, for 6 months or to usual psychosocial care. The primary outcome was parents’ symptoms of posttraumatic stress disorder (PTSD) at 6 and 12 months after enrolment. The secondary outcomes were parents’ symptoms of depression and anxiety. Results: We enrolled 109 families (204 parents). Parents in the intervention group did not show a statistically significant decrease in symptoms of PTSD as compared with the control group at 6 months (predicted mean difference, −0.10; 95% confidence interval [CI] −0.19, 0.01), but a statistically significant decrease was seen at 12 months (predicted mean difference, −0.15; 95% CI −0.28, −0.02), and they had significantly lower symptoms of depression at both 6 and 12 months. Differences in reductions in symptoms of anxiety were not statistically significant. Conclusions: The FAMOS intervention reduced parents’ symptoms of PTSD and depression. Next step is to also report on psychological effects in the children and siblings (clinicaltrials.gov: NCT02200731).
AB - Introduction: Evidence-based knowledge is needed to reduce psychological symptoms in families of young children with cancer after treatment ends. Objective: To evaluate the effect of a psychotherapeutic intervention, FAMily-Oriented Support (FAMOS) on parents of young children after cancer treatment. Methods: All families of children aged 0-6 years who had been treated for cancer at one of the four paediatric oncology departments in Denmark were invited to participate after ending intensive medical treatment. The families were randomly assigned 1:1 to up to seven sessions of FAMOS, a cognitive-behavioural manualised home intervention, for 6 months or to usual psychosocial care. The primary outcome was parents’ symptoms of posttraumatic stress disorder (PTSD) at 6 and 12 months after enrolment. The secondary outcomes were parents’ symptoms of depression and anxiety. Results: We enrolled 109 families (204 parents). Parents in the intervention group did not show a statistically significant decrease in symptoms of PTSD as compared with the control group at 6 months (predicted mean difference, −0.10; 95% confidence interval [CI] −0.19, 0.01), but a statistically significant decrease was seen at 12 months (predicted mean difference, −0.15; 95% CI −0.28, −0.02), and they had significantly lower symptoms of depression at both 6 and 12 months. Differences in reductions in symptoms of anxiety were not statistically significant. Conclusions: The FAMOS intervention reduced parents’ symptoms of PTSD and depression. Next step is to also report on psychological effects in the children and siblings (clinicaltrials.gov: NCT02200731).
KW - anxiety
KW - cancer
KW - cognitive behavioural psychotherapy
KW - depression
KW - family
KW - posttraumatic stress disorder
KW - randomised controlled trial
U2 - 10.1002/pbc.28853
DO - 10.1002/pbc.28853
M3 - Journal article
C2 - 33369038
AN - SCOPUS:85098163883
VL - 68
JO - Pediatric Blood & Cancer
JF - Pediatric Blood & Cancer
SN - 1545-5009
IS - 3
M1 - e28853
ER -
ID: 255458540